Profile of sales and notifications of suspected adverse events related to hydroxychloroquine and chloroquine during the COVID-19 pandemic. RSD [Internet]. 2023 Jan. 30 [cited 2025 Jun. 28];12(2):e15112240021. Available from: https://ojs34.rsdjournal.org/index.php/rsd/article/view/40021